CELG
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F2679638&ei=oIaaUpjiMKTisQeQfQ&usg=AFQjCNEAOqlJXJHZ5Yeq-4My3yAKomNW_g
Celgene Corp Reaffirms FY 2013 Guidance
Thursday, 24 Jan 2013 07:30am EST
Celgene Corp affirmed fiscal 2013 guidance and expects total net product sales to increase approximately 11% year-over-year to approximately $6.000 billion and adjusted diluted EPS to increase approximately 13% year-over-year to a range of $5.50 to $5.60. GAAP diluted EPS expected to be in the range of $4.67 to $4.79 for fiscal 2013. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $6.1 billion for fiscal 2013.Â 
